TerrenceFrancisBlaschkeMD

Internal Medicine • Stanford, CA

Professor Emeritus, Medicine - Clinical Pharmacology, Stanford University Medical Center

Join to view full profile

Dr. Blaschke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blaschke's full profile

Already have an account?

Office
855 Allardice Way
Stanford, CA 94305
Phone+1 650-575-8364

Education & Training

University of California (San Francisco) School of MedicineResidency, Clinical Pharmacology, 1972 - 1974
NCI NIHNone, Clinical Associate, 1970 - 1972
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1969 - 1970
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 1968 - 1969
Columbia University Vagelos College of Physicians and SurgeonsClass of 1968

Certifications & Licensure

CA State Medical License 1972 - 2016

Publications & Presentations

PubMed

4971 citations
Adherence to Medication
Lars Osterberg, Terrence F. Blaschke
The New England Journal of Medicine. 2005-08-04
273 citations
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories.
Terrence F. Blaschke, Lars Osterberg, Bernard Vrijens, John Urquhart
Annual Review of Pharmacology and Toxicology. 2012-01-11
60 citations
Understanding Forgiveness: Minding and Mining the Gaps Between Pharmacokinetics and Therapeutics
Lars Osterberg, John Urquhart, Terrence F. Blaschke
Clinical Pharmacology and Therapeutics. 2010-10-01

Grant Support

Training Program In Clinical PharmacologyNational Institute Of General Medical Sciences1985–2002
Interactions Between Protease Inhibitors/ Lipid LoweringNational Center For Research Resources2000–2001
Test Effect Of Effect Of Nfv, Rtv &Soft Gel SqvNational Center For Research Resources1999–2000
Oral L Arginine AdministrationNational Center For Research Resources1997–1999
Vascular Responsiveness With The Use Of The Hand-Vein TechniqueNational Center For Research Resources1997
Intravenous And Oral L-Arginine In Normal VolunteersNational Center For Research Resources1997
Effect Of Smoking Cessation On Vascular ReactivityNational Center For Research Resources1997
Aging And In Vivo Vascular ResponsivenessNational Institute On Aging1994–1995
Aging And In Vivo Vascular Responsiveness In ManNational Institute On Aging1985–1993
Clinical PharmacologyNational Institute Of General Medical Sciences1988–1992
Aging And In Vivo Vascular Responsiveness In MenNational Institute On Aging1988–1991
Mentor: Computerized Monitoring Of Therapeutic DecisionAgency For Healthcare Research And Quality1988–1989
Kinetics Of Drug-Drug And Drug-Disease InteractionsNational Institute Of General Medical Sciences1986–1989
Use Of Prophet II With A SUN 3/110 Lc-P5 WorkstationNational Center For Research Resources1987
Mentor Computerized Monitoring Of Therapeutic DecisionsAgency For Healthcare Research And Quality1985–1987
Ketoconazole Administration On Metabolism Of Antipyrine And CaffeineNational Center For Research Resources1985
Antipyrine Disposition During Interferon AdministrationNational Center For Research Resources1985